Watch Ticker

Akari Therapeutics plc ADR (0.01 USD)

Go to Akari Therapeutics plc ADR (0.01 USD) Website

$1.34

(%)

Live

Previous Close

$1.34

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$10.6 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Akari Therapeutics Plc - Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics

BOSTON and LONDON, May 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, today announced leadership changes, including the appointment of experienced life sciences entrepreneur Samir R. Patel, M.D. as interim CEO.

Related tickers: AKTX.

Read Full Article

Akari Therapeutics Plc - Akari Therapeutics Reports Full-Year 2023 Financial Results and Recent Highlights

BOSTON and LONDON, April 01, 2024 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, has reported financial results for the full year 2023 as well as recent company highlights.

Related tickers: AKTX.

Read Full Article

Trending Tickers

LASE

XNAS

$2.07

(%)

PACW

XNAS

$7.54

(%)

SMFL

XNAS

$3.37

(%)

XNYS

$73.53

(%)

MLGO

XNAS

$0.00

(%)